JPMorgan Chase Funding Inc.
CIK 1364743 · last filed 2025-10-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.05M
Companies
5
Total Filings
24
Lifetime Open-Market Net
$7.29M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SKYQ | 10%+ Owner | 281,235 | $3.73 | $1.05M | $0 | 1 | 2025-10-24 |
| CANDELA CORP /DE/ (CLZR) Delisted | 10%+ Owner | 1,590,000 | — | — | $7.43M | 11 | 2008-10-10 |
| ALPHARMA INC (ALO) Delisted | 10%+ Owner | 419,170 | — | — | -$916.3K | 1 | 2008-08-20 |
| CHINDEX INTERNATIONAL INC (CHDX) Delisted | 10%+ Owner | — | — | — | $0 | 1 | 2008-01-14 |
| CYTOGEN CORP (CYTO) Delisted | 10%+ Owner | 61 | $0.30 | $18 | $774.7K | 7 | 2007-12-19 |
Recent Filings · Page 2 of 3
24 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-12-06 | CYTOGEN CORP (CYTO) Delisted | Buy (P) | +87,000 | $51.4K | EDGAR |
| 2007-12-03 | CYTOGEN CORP (CYTO) Delisted | Buy (P) | +7,000 | $4.1K | EDGAR |
| 2007-11-30 | CANDELA CORP /DE/ (CLZR) Delisted | Buy (P) | +95,000 | $585.6K | EDGAR |
| 2007-11-28 | CYTOGEN CORP (CYTO) Delisted | Buy (P) | +329,000 | $194.2K | EDGAR |
| 2007-11-20 | CYTOGEN CORP (CYTO) Delisted | Buy (P) | +23,000 | $14.3K | EDGAR |
| 2007-11-16 | CYTOGEN CORP (CYTO) Delisted | Buy (P) | +676,000 | $408.0K | EDGAR |
| 2007-09-25 | CANDELA CORP /DE/ (CLZR) Delisted | Buy (P) | +98,000 | $779.7K | EDGAR |
| 2007-08-24 | CANDELA CORP /DE/ (CLZR) Delisted | Buy (P) | +34,000 | $269.7K | EDGAR |
| 2007-08-14 | CANDELA CORP /DE/ (CLZR) Delisted | Buy (P) | +203,000 | $1.80M | EDGAR |
| 2007-06-25 | CANDELA CORP /DE/ (CLZR) Delisted | Buy (P) | +37,000 | $425.9K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.